genomic testing expands with evolving lung cancer treatment paradigm
Published 4 years ago • 138 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
0:52
genomic testing is necessary in non-small cell lung cancer
-
1:07:31
precision decisions in genomic testing and targeted treatment of nsclc
-
1:01
biomarkers evolve for treatment of lung cancers
-
2:04
genomic testing personalizes lung cancer treatments
-
5:28
the ever-evolving treatment paradigm for nsclc
-
6:04
genetic testing in non–small cell lung cancer
-
2:32
genomic testing for lung cancer in the uk
-
4:23
evolution of targeted therapy in advanced nsclc
-
1:02:08
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
1:02:02
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
0:30
nsclc webinar promo: the evolving landscape of research into lung cancer treatment
-
1:46
why genomic testing is important for cancer treatment
-
1:08
the role of molecular driver identification continues to expand in nsclc
-
1:00:20
it’s precisely the time for more precision in genomic testing and targeted treatment of nsclc
-
6:45
evolution of ngs testing in lung cancers
-
2:22
dr. pennell on the evolution of targeting her2 in lung cancer
-
1:09
increasing genomic testing for non-small cell lung cancer
-
6:13
evolving treatment for nsclc: targeted therapies - 2022 program: targeted therapies forum